Fulminant type 1 diabetes mellitus with anti‐programmed cell death‐1 therapy

Anti‐programmed cell death‐1 (PD‐1) antibodies are regarded as a risk factor for insulin‐dependent diabetes mellitus as a side‐effect. While a small number of cases have been reported, evidence remains limited. This is the first report of an Asian patient developing insulin‐dependent diabetes during...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Diabetes Investig
Autors principals: Okamoto, Masahide, Okamoto, Mitsuhiro, Gotoh, Koro, Masaki, Takayuki, Ozeki, Yoshinori, Ando, Hisae, Anai, Manabu, Sato, Asami, Yoshida, Yuichi, Ueda, So, Kakuma, Tetsuya, Shibata, Hirotaka
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2016
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5089956/
https://ncbi.nlm.nih.gov/pubmed/27181090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12531
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars